Patients with bipolar disorder and comorbidities are typically more complex cases, involving poorer recovery and a less favourable disease course, than patients with bipolar disorder without medical or psychiatric comorbidities.1 The Canadian Network for Mood and Anxiety Treatments (CANMAT) guidance summarized on the slide was an attempt to produce a clear evidence- and consensus-based guide to helping patients with these comorbidities.1The CANMAT guidance for managing medical and psychiatric comorbidity in individuals with MDD or BD stress the importance of screening patients for comorbid conditions.
BD=bipolar disorder; MDD=major depressive disorder
Related content
People with BD can experience residual symptoms that impact on functioning and QoL – these symptoms can benefit from an integrated approach to treatment
Bipolar disorder (BD) includes several disorders of emotion, thought, and energy, characterized by biphasic mood episodes of mania or hypomania and depression.
It is estimated that 57% of patients with bipolar disorder are not fully adherent to medication